This is a real step function level improvement in the capability of AI driven drug design. @nablabio is able to fully design a multifunctional/multispecific biologic de novo. This is the way to get to N of 1 personalized biologics.
Today, we expand zero-shot drug design beyond binding to the design of multifunctional medicines, the intracellular proteome, and state-of-the-art atomic precision with our model, JAM-2.
In a new report (below), we show:
1. The first drug-grade, fully computationally designed
